References
- Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002;15(1):79–94. doi:https://doi.org/10.1128/cmr.15.1.79-94.2002
- Tran CD, Katsikeros R, Abimosleh SM. Current and novel treatments for ulcerative colitis. In: Ulcerative colitis from genetics to complications. London: IntechOpen Limited; 2012. p. 189–211.
- Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389(10080):1756–70. doi:https://doi.org/10.1016/S0140-6736(16)32126-2
- Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis. 2003;24(3):353–62. doi:https://doi.org/10.1093/carcin/24.3.353
- Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut. 1994;35(7):950–4. doi:https://doi.org/10.1136/gut.35.7.950
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492
- Dulai PS, Sandborn WJ, Gupta S. Colorectal cancer and dysplasia in inflammatory bowel disease: a review of disease epidemiology, pathophysiology, and management. Cancer Prev Res. 2016;9(12):887–94. doi:https://doi.org/10.1158/1940-6207.CAPR-16-0124
- Kinugasa T, Akagi Y. Status of colitis-associated cancer in ulcerative colitis. World J Gastrointest Oncol. 2016;8(4):351–7. doi:https://doi.org/10.4251/wjgo.v8.i4.351
- Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490–502. doi:https://doi.org/10.1016/S0140-6736(13)61649-9
- Herszenyi L, Barabas L, Miheller P, Tulassay Z. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk. Dig Dis. 2015;33(1):52–7. doi:https://doi.org/10.1159/000368447
- Lucas C, Barnich N, Nguyen HTT. Microbiota, inflammation and colorectal cancer. Int J Mol Sci. 2017;18(6):1310. doi:https://doi.org/10.3390/ijms18061310
- Zheng H, Lu Z, Wang R, Chen N, Zheng P. Establishing the colitis-associated cancer progression mouse models. Int J Immunopathol Pharmacol. 2016;29(4):759–63. doi:https://doi.org/10.1177/0394632016670919
- Whitehouse MW, Turner AG, Davis CK, Roberts MS. Emu oil(s): a source of non-toxic transdermal anti-inflammatory agents in aboriginal medicine. Inflammopharmacology. 1998;6(1):1–8. doi:https://doi.org/10.1007/s10787-998-0001-9
- Snowden JM, Whitehouse MW. Anti-inflammatory activity of emu oils in rats. Inflammopharmacology. 1997;5(2):127–32. doi:https://doi.org/10.1007/s10787-997-0021-x
- Beckerbauer LM, Thiel-Cooper R, Ahn DU, Sell JL, Parrish FC, Beitz DC, Jr. Influence of two dietary fats on the composition of emu oil and meat. Poult Sci. 2001;80(2):187–94. doi:https://doi.org/10.1093/ps/80.2.187
- Abimosleh SM, Tran CD, Howarth GS. Emu Oil: a novel therapeutic for disorders of the gastrointestinal tract? J Gastroenterol Hepatol. 2012;27(5):857–61. doi:https://doi.org/10.1111/j.1440-1746.2012.07098.x
- Mashtoub S, Bennett DC, Tran CD, Howarth GS. Processing and storage of ratite oils affects primary oxidation status and radical scavenging ability. Anim Prod Sci. 2015;55(10):1332–7. doi:https://doi.org/10.1071/AN13556
- Bennett DC, Code WE, Godin DV, Cheng KM. Comparison of the antioxidant properties of emu oil with other avian oils. Aust J Exp Agric. 2008;48(10):1345–50. doi:https://doi.org/10.1071/EA08134
- Abimosleh SM, Lindsay RJ, Butler RN, Cummins AG, Howarth GS. Emu oil increases colonic crypt depth in a rat model of ulcerative colitis. Dig Dis Sci. 2012;57(4):887–96. doi:https://doi.org/10.1007/s10620-011-1979-1
- Safaeian R, Howarth GS, Lawrance IC, Trinder D, Mashtoub S. Emu Oil reduces disease severity in a mouse model of chronic ulcerative colitis. Scand J Gastroenterol. 2019;54(3):273–280 . doi:https://doi.org/10.1080/00365521.2019.1581253
- Mashtoub S, Tran CD, Howarth GS. Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in rats. Exp Biol Med (Maywood)). 2013;238(11):1305–17. doi:https://doi.org/10.1177/1535370213493718
- Mashtoub S, Lampton LS, Eden GL, Cheah KY, Lymn KA, Bajic JE, Howarth GS. Emu oil combined with Lyprinol™ reduces small intestinal damage in a rat model of chemotherapy-induced mucositis. Nutr Cancer. 2016;68(7):1171–80. doi:https://doi.org/10.1080/01635581.2016.1208829
- Abimosleh SM, Tran CD, Howarth GS. Emu oil reduces small intestinal inflammation in the absence of clinical improvement in a rat model of indomethacin-induced enteropathy. Evid Based Complement Alternat Med. 2013;2013:1–10. 10, doi:https://doi.org/10.1155/2013/429706
- Chartier LC, Howarth GS, Lawrance IC, Trinder D, Barker SJ, Mashtoub S. Emu oil improves clinical indicators of disease in a mouse model of colitis-associated colorectal cancer. Dig Dis Sci. 2018;63(1):135–45. doi:https://doi.org/10.1007/s10620-017-4876-4
- Mashtoub S, Feo B, Whittaker AL, Lymn KA, Martinez-Puig D, Howarth GS. Oral Nucleotides Only Minimally Improve 5-Fluorouracil-Induced Mucositis in Rats. Nutr Cancer. 2015;67(6):994–1000. doi:https://doi.org/10.1080/01635581.2015.1062118
- Howarth GS, Xian CJ, Read LC. Predisposition to colonic dysplasia is unaffected by continuous administration of insulin-like growth factor-I for twenty weeks in a rat model of chronic inflammatory bowel disease. Growth Factors. 2000;18(2):119–33. doi:https://doi.org/10.3109/08977190009003238
- Yazbeck R, Howarth GS, Geier MS, Demuth HU, Abbott CA. Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice. Front Biosci. 2008;13:6850–8. doi:https://doi.org/10.2741/3193
- Howarth GS, Francis GL, Cool JC, Xu X, Byard RW, Read LC. Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats. J Nutr. 1996;126(10):2519–30. doi:https://doi.org/10.1093/jn/126.10.2519
- De Robertis M, Massi E, Poeta ML, Carotti S, Morini S, Cecchetelli L, Signori E, Fazio VM. The AOM/DSS murine model for the study of colon carcinogenesis: from pathways to diagnosis and therapy studies. J Carcinog. 2011;10:9. doi:https://doi.org/10.4103/1477-3163.78279
- Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 2003;94(11):965–73. doi:https://doi.org/10.1111/j.1349-7006.2003.tb01386.x
- Mazewski C, Luna D, Berhow M, Gonzalez de Mejia E. Reduction of colitis-associated colon carcinogenesis by a black lentil water extract through inhibition of inflammatory and immunomodulatory cytokines. Carcinogenesis. 2020;41(6):790–803. doi:https://doi.org/10.1093/carcin/bgaa008
- Damazo-Lima M, Rosas-Pérez G, Reynoso-Camacho R, Pérez-Ramírez IF, Rocha-Guzmán NE, de los Ríos EA, Ramos-Gomez M. Chemopreventive effect of the germinated oat and its phenolic-AVA extract in azoxymethane/dextran sulfate sodium (AOM/DSS) model of colon carcinogenesis in mice. Foods. 2020;9(2):169. doi:https://doi.org/10.3390/foods9020169
- Neergheen VS, Bahorun T, Taylor EW, Jen LS, Aruoma OI. Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention. Toxicology. 2010;278(2):229–41. doi:https://doi.org/10.1016/j.tox.2009.10.010
- Becker C, Fantini MC, Wirtz S, Nikolaev A, Kiesslich R, Lehr HA, Galle PR, Neurath MF. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut. 2005;54(7):950–4. doi:https://doi.org/10.1136/gut.2004.061283
- Chartier LC, Hebart ML, Howarth GS, Whittaker AL, Mashtoub S. Affective state determination in a mouse model of colitis-associated colorectal cancer. PLoS One. 2020;15(1):e0228413. doi:https://doi.org/10.1371/journal.pone.0228413
- Chartier LC, Howarth GS, Mashtoub S. Chemotherapy-induced mucositis development in a murine model of colitis-associated colorectal cancer. Scand J Gastroenterol. 2020;55(1):47–54. doi:https://doi.org/10.1080/00365521.2019.1699601
- Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015;148(6):1244–60 e16. doi:https://doi.org/10.1053/j.gastro.2014.12.035
- Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981;66(6):1191–308.
- Song JL, Lee JS, Kim HY, Jeong BJ, Jeong JS. Dietary mixed cereal grains ameliorate the azoxymethane and dextran sodium sulfate-induced colonic carcinogenesis in C57BL/6J mice. J Med Food. 2020;23(4):440–452. doi:https://doi.org/10.1089/jmf.2019.4540
- Ma J, Rubin BK, Voynow JA. Mucins, mucus, and goblet cells. Chest. 2018;154(1):169–76. doi:https://doi.org/10.1016/j.chest.2017.11.008
- Zhang J, Yasin M, Carraway CA, Carraway KL. MUC4 expression and localization in gastrointestinal tract and skin of human embryos. Tissue Cell. 2006;38(4):271–5. doi:https://doi.org/10.1016/j.tice.2006.06.004
- Shanmugam C, Jhala NC, Katkoori VR, Wan W, Meleth S, Grizzle WE, Manne U. Prognostic value of mucin 4 expression in colorectal adenocarcinomas. Cancer. 2010;116(15):3577–86. doi:https://doi.org/10.1002/cncr.25095
- Das S, Rachagani S, Sheinin Y, Smith LM, Gurumurthy CB, Roy HK, Batra SK. Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer. Oncogene. 2016;35(20):2645–54. doi:https://doi.org/10.1038/onc.2015.327
- Chen J-R, Chen Y-L, Peng H-C, Lu Y-A, Chuang H-L, Chang H-Y, Wang H-Y, Su Y-J, Yang S-C. Fish oil reduces hepatic injury by maintaining normal intestinal permeability and microbiota in chronic ethanol-fed rats. Gastroenterol Res Pract. 2016;2016:4694726. doi:https://doi.org/10.1155/2016/4694726
- Horie T, Nakamaru M, Masubuchi Y. Docosahexaenoic acid exhibits a potent protection of small intestine from methotrexate-induced damage in mice. Life Sci. 1998;62(15):1333–8. doi:https://doi.org/10.1016/s0024-3205(98)00067-8